07/27/2026 | Companies

AccPCC, ADC, AI-enabled platform, analytical development, antibodies, antibody-drug conjugates, AsymBio, Asymchem Group, biologics, biologics development, biologics manufacturing, biopharmaceuticals, biotech partnerships, biotechnology, CDMO, cell line development, chemistry manufacturing and controls, clinical manufacturing, CMC, commercial manufacturing, conjugation process, contract development, contract manufacturing, downstream processing, drug development, drug product development, Fengxian, global biotech, green building, innovation, life sciences, low-carbon infrastructure, manufacturing excellence, PCC selection, pharmaceutical manufacturing, pharmaceutical research, preclinical candidate, process development, R&D expansion, R&D facility, research and development, scale-up manufacturing, science to clinic, Shanghai, sustainable construction, technology transfer, translational research, upstream processing